2Vitali C, Bombardieri S, Jonsson R, et al, Classication criteria for Sjogren' s syndrome [J]. Ann Rheum Dis, 2002, 61: 554～558.
3D' Arbonneau F, Ansart S, Le Berre R, et al, Thyroid dysfunction in primary Sjogren' s syndrome: a long-term followup study [J].Arthritis Rheum, 2003, 15, 49 (6): 804 ～ 809.
4Coll J, Tomas S, Anglada J, etal. Prevalence of Sjogren' ssyndrome in autoimmune thyroid disease [J]. Brest, 1994, J Rheumatol,1997, Sep, 24 (9): 1719～ 1724.
5Ozgen AG, Keser G, Erdem N, et al, Hypothalamus-hypophysisthyroid axis, triiodothyronine and antithyroid antibodies in patients with primary and secondary Sjogren' s syndrome [ J ]. Clin Rheumatol,2001, 20 (1): 44～48.
2Vitali C, Bombardieri S, Jonsson R, et al. Classification criteria for Sjogren's syndrome: a revised version of the European criteria proposed by the American-European Consensus Group[J]. Ann Rheum Dis, 2002, 61(6): 554-558.
3Jara LJ, Navarro C. Thyroid disease in Sjogren's syndrome[J].Clin Rheumatol,2007, 26(10) : 1601-1606.
4Gomez LM, Anaya JM, Gonzalez CI, et al. PTPN22 C1858T polymorphism in Colombian patients with autoimmune diseases [J]. Genes Immun,2005, 6(7):628-631.
5Wu H, Cantor RM, Graham DS,et al. Association analysis of the R620W polymorphism of protein tyrosine phosphatase PTPN22 in systemic lupus erythematosus families: increased T allele frequency in systemic lupus erythematosus patients with autoimmune thyroid disease[J]. Arthritis Rheum, 2005, 52(8) : 2396-2402.
